BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15368472)

  • 1. Trefoil factor 3 is overexpressed in human prostate cancer.
    Garraway IP; Seligson D; Said J; Horvath S; Reiter RE
    Prostate; 2004 Nov; 61(3):209-14. PubMed ID: 15368472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
    Faith DA; Isaacs WB; Morgan JD; Fedor HL; Hicks JL; Mangold LA; Walsh PC; Partin AW; Platz EA; Luo J; De Marzo AM
    Prostate; 2004 Nov; 61(3):215-27. PubMed ID: 15368473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of TFF1 and TFF3 in prostate cancer and prostatic intraepithelial neoplasia and their clinical significance].
    Liu M; Jin RS
    Zhonghua Nan Ke Xue; 2015 Apr; 21(4):315-9. PubMed ID: 26027097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer.
    Vestergaard EM; Borre M; Poulsen SS; Nexø E; Tørring N
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):807-12. PubMed ID: 16467092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.
    Park K; Chiu YL; Rubin MA; Demichelis F; Mosquera JM
    Hum Pathol; 2013 Oct; 44(10):2282-92. PubMed ID: 23856515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trefoil factor family gene and peptide expression in pterygium].
    Lafontaine PO; Arnal M; Buron N; Solary E; Lizard S; Bron A; Bara J; Gespach C; Creuzot-Garcher C
    J Fr Ophtalmol; 2003 Dec; 26(10):1007-14. PubMed ID: 14691392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation.
    Perera O; Evans A; Pertziger M; MacDonald C; Chen H; Liu DX; Lobie PE; Perry JK
    Cancer Lett; 2015 May; 361(1):104-11. PubMed ID: 25748388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
    Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR
    Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
    Dhar DK; Wang TC; Tabara H; Tonomoto Y; Maruyama R; Tachibana M; Kubota H; Nagasue N
    Clin Cancer Res; 2005 Sep; 11(18):6472-8. PubMed ID: 16166422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
    Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
    Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
    Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
    Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
    Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
    Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
    Xu C; Zhou T; He M; Sun Y
    Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypomethylation and upregulation of trefoil factors in prostate cancer.
    Vestergaard EM; Nexø E; Tørring N; Borre M; Ørntoft TF; Sørensen KD
    Int J Cancer; 2010 Oct; 127(8):1857-65. PubMed ID: 20112343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.